Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Oxeia Biopharmaceuticals
AddedFeb 18, 2024
UpdatedJun 18, 2026
Oxeia Biopharmaceuticals

Oxeia Biopharmaceuticals

Oxeia Biopharmaceuticals: Innovating concussion treatments with our clinical-stage drug, OXE103.

HQ
Boston, MA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Oxeia Biopharmaceuticals, founded to address the unmet medical needs in treating mild traumatic brain injury (mTBI), focuses on developing innovative therapeutics for concussions and related neuro-metabolic dysfunctions. The company's core mission is to improve the quality of life for patients suffering from these conditions through advanced drug therapies. Their flagship product, OXE103, is a clinical-stage drug that began Phase 2 trials in fall 2020, aiming to provide effective treatment options where currently few exist.

Notable individuals affiliated with Oxeia Biopharmaceuticals include researchers from KU Medical Center who are testing the efficacy of OXE103. The company has garnered attention for its promising early results in improving concussion symptoms and overall quality of life for patients. With its pioneering approach and significant strides in clinical trials, Oxeia Biopharmaceuticals is making a substantial impact in the field of neuro-metabolic dysfunction and concussion treatment.

Oxeia Biopharmaceuticals - Similar Companies

OX2 Therapeutics logo

OX2 Therapeutics

Oxalo Therapeutics logo

Oxalo Therapeutics

Ocelot Bio logo

Ocelot Bio

ocelotbio.com

Oviva Therapeutics logo

Oviva Therapeutics

ovivatx.com

Astrocyte Pharmaceuticals logo

Astrocyte Pharmaceuticals

Xoc Pharmaceuticals logo

Xoc Pharmaceuticals

Omniox logo

Omniox

Blue Oak Pharmaceuticals logo

Blue Oak Pharmaceuticals

blueoakpharma.com

NuvOx Pharma logo

NuvOx Pharma

nuvoxpharma.com

BioHealthonomics logo

BioHealthonomics

Xeno Biosciences logo

Xeno Biosciences

NeurAegis logo

NeurAegis

neuraegis.com

Visiox logo

Visiox

visioxpharma.com

Axerion Therapeutics logo

Axerion Therapeutics

Therapyx logo

Therapyx

therapyxinc.com

Oxeia Biopharmaceuticals - Quick Facts

Who are Oxeia Biopharmaceuticals' competitors?

Companies similar to Oxeia Biopharmaceuticals include OX2 Therapeutics, Oxalo Therapeutics, Ocelot Bio and Oviva Therapeutics.

When was Oxeia Biopharmaceuticals founded?

Oxeia Biopharmaceuticals was founded in 2014.

Where is Oxeia Biopharmaceuticals' headquarters located?

Oxeia Biopharmaceuticals' headquarters is located in Boston, MA, US.

How much has Oxeia Biopharmaceuticals raised to-date?

As of Oct 31, 2017, Oxeia Biopharmaceuticals has raised a total of $310k (USD).

How many employees does Oxeia Biopharmaceuticals have?

Oxeia Biopharmaceuticals has 9 employees as of Feb 5, 2024.

Oxeia Biopharmaceuticals - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research